Medical and oncological management of malignant mesothelioma.

Anna C Bibby, Lara Gibbs, Jeremy P Braybrooke

Journal: British journal of hospital medicine (London, England : 2005) 2015;76(7):384-9

PMID: 26140556

Abstract

Mesothelioma is an aggressive cancer, for which no curative oncological treatment currently exists. This article outlines the options for managing malignant pleural effusions, describes the developments in chemotherapy over the past 10 years and summarizes the evidence for prophylactic and palliative radiotherapy.

Address: Specialist Registrar in the Department of Respiratory Medicine, Bristol Royal Infirmary, Bristol BS2 8HW.; Specialist Registrar.; Consultant Medical Oncologist, Bristol Haematology & Oncology Centre, Bristol.

DOI: 10.12968/hmed.2015.76.7.384

Link outs

Free resources

Medical:

https://medlineplus.gov/mesothelioma.html

Miscellaneous:

https://assays.cancer.gov/CPTAC-68

Subscription / membership required

Full Text Sources:

https://www.magonlinelibrary.com/doi/10.12968/hmed...

MeSH Terms: Antineoplastic Agents, Catheters, Indwelling, Chest Tubes, Folic Acid Antagonists, Humans, Lung Neoplasms, Mesothelioma, Mesothelioma, Malignant, Pleural Effusion, Malignant